Episode Details

Back to Episodes
Pharmaceutical Executive Daily: September 4, 2025

Pharmaceutical Executive Daily: September 4, 2025

Published 8 months, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover political pressure on Moderna and Novavax to release COVID-19 vaccine evidence, a deep dive into the evolving GLP-1 market, and Sanofi’s share decline following disappointing Phase III results for Amlitelimab.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us